Literature DB >> 16034439

Effect of acute tyrosine depletion in using a branched chain amino-acid mixture on dopamine neurotransmission in the rat brain.

Marisa Le Masurier1, Weite Oldenzeil, Claire Lehman, Philip Cowen, Trevor Sharp.   

Abstract

Central dopamine function is reduced by decreasing the availability of the catecholamine precursor, tyrosine, using a tyrosine-free amino acid mixture containing multiple large neutral as well as branched chain amino-acids, which compete with tyrosine for uptake into the brain. Current mixtures are cumbersome to make and administer, and unpalatable to patients and volunteers. Here, we investigate whether individual or limited amino-acid combinations could reduce brain tyrosine levels and hence dopamine function. Measurements of regional brain tyrosine levels, catecholamine and indoleamine synthesis (L-DOPA and 5-HTP accumulation, respectively) were used to identify an effective paradigm to test in neurochemical, behavioral and fos immunocytochemical models. Administration of leucine or isoleucine, or a mixture of leucine, isoleucine, and valine reduced tyrosine and 5-HTP, but not L-DOPA accumulation. A mixture of leucine, valine, and isoleucine supplemented with tryptophan reduced brain tyrosine and L-DOPA, but not 5-HTP. In microdialysis experiments this amino-acid mixture reduced basal and amphetamine-evoked striatal dopamine release, as well as amphetamine-induced hyperactivity. This mixture also reduced amphetamine-induced fos expression in striatal areas. In conclusion, the present study identified a small combination of amino acids that reduces brain tyrosine and dopamine function in a manner similar to mixtures of multiple amino acids. This minimal mixture may have use as a dopamine reducing paradigm in patient and volunteer studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16034439     DOI: 10.1038/sj.npp.1300835

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  8 in total

1.  L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions.

Authors:  Joseph M Breier; Michael G Bankson; Bryan K Yamamoto
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

2.  Acute oral administration of a tyrosine and phenylalanine-free amino acid mixture reduces exercise capacity in the heat.

Authors:  Les Tumilty; Glen Davison; Manfred Beckmann; Rhys Thatcher
Journal:  Eur J Appl Physiol       Date:  2013-01-04       Impact factor: 3.078

3.  Acute phenylalanine/tyrosine depletion of phasic dopamine in the rat brain.

Authors:  Tatiana A Shnitko; Sarah C Taylor; Sierra J Stringfield; Shannon L Zandy; Roberto U Cofresí; James M Doherty; William B Lynch; Charlotte A Boettiger; Rueben A Gonzales; Donita L Robinson
Journal:  Psychopharmacology (Berl)       Date:  2016-03-05       Impact factor: 4.530

4.  Specificity of the Acute Tryptophan and Tyrosine Plus Phenylalanine Depletion and Loading Tests Part II: Normalisation of the Tryptophan and the Tyrosine Plus Phenylalanine to Competing Amino Acid Ratios in a New Control Formulation.

Authors:  Abdulla A-B Badawy; Donald M Dougherty; Dawn M Richard
Journal:  Int J Tryptophan Res       Date:  2010

5.  Simplified dietary acute tryptophan depletion: effects of a novel amino acid mixture on the neurochemistry of C57BL/6J mice.

Authors:  Cristina L Sánchez; Amanda E D Van Swearingen; Andrew E Arrant; Caroline S Biskup; Cynthia M Kuhn; Florian D Zepf
Journal:  Food Nutr Res       Date:  2015-08-13       Impact factor: 3.894

6.  Plasma phenylalanine and tyrosine and their interactions with diabetic nephropathy for risk of diabetic retinopathy in type 2 diabetes.

Authors:  Hui-Huan Luo; Juan Li; Xiao-Fei Feng; Xiao-Yu Sun; Jing Li; Xilin Yang; Zhong-Ze Fang
Journal:  BMJ Open Diabetes Res Care       Date:  2020-09

7.  Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.

Authors:  William J Zinnanti; Jelena Lazovic; Kathleen Griffin; Kristen J Skvorak; Harbhajan S Paul; Gregg E Homanics; Maria C Bewley; Keith C Cheng; Kathryn F Lanoue; John M Flanagan
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

8.  A Preclinical Study of Casein Glycomacropeptide as a Dietary Intervention for Acute Mania.

Authors:  Nico Liebenberg; Erik Jensen; Erik Roj Larsen; Birgitte Saima Kousholt; Vitor Silva Pereira; Christina Weide Fischer; Gregers Wegener
Journal:  Int J Neuropsychopharmacol       Date:  2018-05-01       Impact factor: 5.176

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.